PCN69 COST-EFFECTIVENESS OF ADDING CAPECITABINE TO TRASTUZUMAB AND DOCETAXEL AS FIRST LINE THERAPY FOR PATIENTS WITH HER-2-POSITIVE METASTATIC BREAST CANCER (HER2+MBC)—RESULTS FROM SPAIN, FRANCE AND ITALY

✍ Scribed by K Hieke; P Ducournau; F de Reydet de Vulpillières

• Book ID: 118611913
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 71 KB
• Volume: 12
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)74320-5